U.S. vendors look to global sales to balance slowdown at home

Article

Latin American opportunities on the riseWith U.S. medical imaging system shipments slumping 3% in 1993and potentially declining by as much as 5% this year, internationalsales provide some good news for American manufacturers. U.S.imaging

Latin American opportunities on the rise

With U.S. medical imaging system shipments slumping 3% in 1993and potentially declining by as much as 5% this year, internationalsales provide some good news for American manufacturers. U.S.imaging vendors have an advantage in approaching one of the brightestof the international bright spots, Latin America, according toMorgan W. Nields, chairman and CEO of Denver-based Fischer Imaging.

Nields spoke at the Diagnostic Imaging conference in San Franciscolast month, entitled Opportunities for the Imaging Industry: Prospectsand Challenges in the `90s (see story, page one).

U.S. medical imaging exports have doubled over the last fiveyears, according to Nields. Exports of imaging equipment amountedto almost $2.3 billion in 1993, up from just over $1 billion in1988.

Western Europe received almost half of U.S. medical imagingexports last year, while Japan counted for only 13%, Nields said(see chart). This contrasts with Japan's economic potential, whichis about half that of Europe. Japan takes a greater percentageof worldwide medical imaging sales due to the business of Japanese-basedsuppliers.

While there has been much industry discussion of Chinese salespotential, the China market accounted for only 3.3% of U.S. medicalimaging exports last year, he said. Latin America, on the otherhand, took 11% of U.S. medical imaging exports in 1993, up from7% in 1988.

While Latin America holds great potential for all imaging suppliers,U.S. firms in particular benefit from the growing momentum ofregional free trading pacts, he said.

The North American Free Trade Agreement will give U.S.-basedfirms a considerable advantage by circumventing the 10% duty ratesin Mexico. In addition, fast-developing Chile could join NAFTAwithin a year, with Argentina not far behind and Columbia andVenezuela on the horizon, he said.

"By the year 2000, I predict that we will have a freetrade zone in the Western Hemisphere. By that time, this willoffer a market of about 900 million people, all within two timezones of most places in the U.S.," Nields said.

Existing trading blocs among Latin American countries are fasttrimming by half the protectionist duty rates that were formerlyaround 40%, he said. Privatization is on the rise, led by Argentina,with Mexico close behind. Even Bolivia has gotten into the privatizationact through the formation of a giant public employee stock optionplan.

Democratization and economic growth are moving in tandem inLatin America. The fastest growing countries are Chile, Argentinaand Mexico. Double digit economic growth has been realized inmost cases, with inflation rising at only 5% to 8% a year. Thiswas unheard of in the region five years ago, Nields said.

"This (Latin America) is one of the best near-term opportunitieswe have in imaging," Nields said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.